These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26855094)

  • 41. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
    Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
    Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
    Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate.
    Nault AM; Peipert JF; Zhao Q; Madden T; Secura GM
    Am J Obstet Gynecol; 2013 Jan; 208(1):48.e1-8. PubMed ID: 23103344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand.
    Colli E; Tong D; Penhallegon R; Parazzini F
    Contraception; 1999 Apr; 59(4):227-31. PubMed ID: 10457866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device.
    Hinz EK; Murthy A; Wang B; Ryan N; Ades V
    Contraception; 2019 Aug; 100(2):101-105. PubMed ID: 31108053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The safety of intrauterine devices among young women: a systematic review.
    Jatlaoui TC; Riley HEM; Curtis KM
    Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
    Bahamondes L; Brache V; Ali M; Habib N;
    Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM; Gola SB; Weis M; Smaldone A
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
    Eggebroten JL; Sanders JN; Turok DK
    Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate.
    Modesto W; Bahamondes MV; Bahamondes L
    J Womens Health (Larchmt); 2015 Aug; 24(8):636-40. PubMed ID: 26098552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does access to no-cost contraception change method selection among individuals who report difficulty paying for health-related care?
    Gero A; Simmons RG; Sanders JN; Turok DK
    BMC Womens Health; 2022 Aug; 22(1):327. PubMed ID: 35918666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
    Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
    Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of Early Discontinuation of Effective Contraception by Teens at High Risk of Pregnancy.
    Maslyanskaya S; Coupey SM; Chhabra R; Khan UI
    J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):269-75. PubMed ID: 26526036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
    Tang JH; Lopez LM; Mody S; Grimes DA
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009805. PubMed ID: 23152281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk.
    Raine-Bennett T; Chandra M; Armstrong MA; Alexeeff S; Lo JC
    Obstet Gynecol; 2019 Sep; 134(3):581-589. PubMed ID: 31403601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L; Marchi NM; Castro S; Juliato CT; Villarroel M; Bahamondes L
    Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.